Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23726161 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Clinical Trial to Assess the Efficacy and Safety of an Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children Aged 6-35 Months
Conditions: Hand, Foot and Mouth Disease;   Herpangina;   Other EV71-associated Diseases
Interventions: Biological: inactivated vaccine (Vero Cell) against EV71;   Biological: 0/0.5ml placebo

Indicates status has not been verified in more than two years